Overview

Prucalopride and Cognition in Recovered Depression

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The current study has two aims: 1. To test the effect of 5-HT4 receptor agonism on cognition (including memory, attention and cognitive control) in individuals with previous history of depression. 2. To explore if prucalopride has an effect on emotional processing biases consistent with its effects on serotonin.
Phase:
Early Phase 1
Details
Lead Sponsor:
University of Oxford
Treatments:
Prucalopride